Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-051292
Filing Date
2022-04-27
Accepted
2022-04-27 17:01:08
Documents
4
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223386-2_def14a.htm DEF 14A 686906
2 GRAPHIC lg_jaguarhealth-4c.jpg GRAPHIC 68832
3 GRAPHIC sg_lisaaconte-bw.jpg GRAPHIC 16200
4 GRAPHIC tm223386d1-px_votingbw.jpg GRAPHIC 637006
  Complete submission text file 0001104659-22-051292.txt   1678628
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36714 | Film No.: 22860714
SIC: 2834 Pharmaceutical Preparations